Cargando…
Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function
OBJECTIVE: Chronic inflammation and fibrosis are characteristic of interstitial lung diseases (ILD) and are accompanied by neovascularisation. The aim of this study was to examine the relationship between the angiogenic activity of sera from ILD patients and pulmonary function tests. MATERIAL AND ME...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360317/ https://www.ncbi.nlm.nih.gov/pubmed/21147657 http://dx.doi.org/10.1186/2047-783X-15-S2-229 |
_version_ | 1782361533488037888 |
---|---|
author | Zielonka, TM Demkow, U Radzikowska, E Bialas, B Filewska, M Zycinska, K Obrowski, MH Kowalski, J Wardyn, KA Skopinska-Rozewska, E |
author_facet | Zielonka, TM Demkow, U Radzikowska, E Bialas, B Filewska, M Zycinska, K Obrowski, MH Kowalski, J Wardyn, KA Skopinska-Rozewska, E |
author_sort | Zielonka, TM |
collection | PubMed |
description | OBJECTIVE: Chronic inflammation and fibrosis are characteristic of interstitial lung diseases (ILD) and are accompanied by neovascularisation. The aim of this study was to examine the relationship between the angiogenic activity of sera from ILD patients and pulmonary function tests. MATERIAL AND METHODS: Serum samples were obtained from 225 ILD patients: 83 with sarcoidosis, 31 with idiopathic pulmonary fibrosis, 29 with extrinsic allergic alveolitis, 16 with collagen vascular diseases, 13 with scleroderma with pulmonary manifestations (SCL), 14 with Wegener's granulomatosis (WG), 12 with silicosis, 12 with pulmonary Langerhans cells histiocytosis, 10 with drug-induced pulmonary fibrosis, 5 with cryptogenic organizing pneumonia, and 36 healthy volunteers. An animal model of leukocyte induced angiogenesis assay was used as an angiogenic test. In all patients spirometry, whole body plethysmography, static lung compliance, and single breath diffusing capacity of the lungs for carbon monoxide (DL(CO)) were performed. RESULTS: The angiogenic properties of sera from ILD differed, depending on the disease. In the examined ILD, the most important functional disturbances were decreases in static compliance and DL(co). The correlation between DL(CO )and angiogenic activity of sera was observed (P < 0.05). CONCLUSIONS: The data show that sera from ILD patients constitute a source of mediators modulating angiogenesis. Angiogenic activity of sera of ILD patients is related to DL(CO). |
format | Online Article Text |
id | pubmed-4360317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43603172015-03-26 Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function Zielonka, TM Demkow, U Radzikowska, E Bialas, B Filewska, M Zycinska, K Obrowski, MH Kowalski, J Wardyn, KA Skopinska-Rozewska, E Eur J Med Res Research OBJECTIVE: Chronic inflammation and fibrosis are characteristic of interstitial lung diseases (ILD) and are accompanied by neovascularisation. The aim of this study was to examine the relationship between the angiogenic activity of sera from ILD patients and pulmonary function tests. MATERIAL AND METHODS: Serum samples were obtained from 225 ILD patients: 83 with sarcoidosis, 31 with idiopathic pulmonary fibrosis, 29 with extrinsic allergic alveolitis, 16 with collagen vascular diseases, 13 with scleroderma with pulmonary manifestations (SCL), 14 with Wegener's granulomatosis (WG), 12 with silicosis, 12 with pulmonary Langerhans cells histiocytosis, 10 with drug-induced pulmonary fibrosis, 5 with cryptogenic organizing pneumonia, and 36 healthy volunteers. An animal model of leukocyte induced angiogenesis assay was used as an angiogenic test. In all patients spirometry, whole body plethysmography, static lung compliance, and single breath diffusing capacity of the lungs for carbon monoxide (DL(CO)) were performed. RESULTS: The angiogenic properties of sera from ILD differed, depending on the disease. In the examined ILD, the most important functional disturbances were decreases in static compliance and DL(co). The correlation between DL(CO )and angiogenic activity of sera was observed (P < 0.05). CONCLUSIONS: The data show that sera from ILD patients constitute a source of mediators modulating angiogenesis. Angiogenic activity of sera of ILD patients is related to DL(CO). BioMed Central 2010-11-04 /pmc/articles/PMC4360317/ /pubmed/21147657 http://dx.doi.org/10.1186/2047-783X-15-S2-229 Text en Copyright © 2010 I. Holzapfel Publishers |
spellingShingle | Research Zielonka, TM Demkow, U Radzikowska, E Bialas, B Filewska, M Zycinska, K Obrowski, MH Kowalski, J Wardyn, KA Skopinska-Rozewska, E Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title | Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title_full | Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title_fullStr | Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title_full_unstemmed | Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title_short | Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
title_sort | angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360317/ https://www.ncbi.nlm.nih.gov/pubmed/21147657 http://dx.doi.org/10.1186/2047-783X-15-S2-229 |
work_keys_str_mv | AT zielonkatm angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT demkowu angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT radzikowskae angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT bialasb angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT filewskam angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT zycinskak angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT obrowskimh angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT kowalskij angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT wardynka angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction AT skopinskarozewskae angiogenicactivityofserafrominterstitiallungdiseasepatientsinrelationtopulmonaryfunction |